Exagen, Inc. (XGN)
6.02
+0.04
(+0.67%)
USD |
NASDAQ |
Dec 30, 13:12
Exagen EPS Diluted (Quarterly): -0.3089 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3368 |
| XWELL, Inc. | -0.2557 |
| ProPhase Labs, Inc. | -1.646 |
| Veracyte, Inc. | 0.2401 |
| Insight Molecular Diagnostics, Inc. | -0.3388 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.087M |
| Revenue (Quarterly) | 17.24M |
| Total Expenses (Quarterly) | 24.33M |
| Enterprise Value | 128.04M |
| Gross Profit Margin (Quarterly) | 58.43% |
| Profit Margin (Quarterly) | -41.10% |
| Earnings Yield | -15.38% |
| Normalized Earnings Yield | -13.62 |